Ultrasound and MRI screening for early liver cancer detection
Part of Cancer, Digestive system clinical trials.
This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a high risk of liver cancer due to things like hepatitis B or C, heavy alcohol use, fatty liver disease, or a family history of liver cancer.
- Your screening risk score (called aMAP) is between 60 and 100, which means you are at higher risk.
- You have not had any imaging test in the past six months that showed a suspicious liver spot.
- You have never been diagnosed with liver cancer or any other type of cancer.
- You are not pregnant or breastfeeding, and you have no severe heart or lung disease.
- Your kidneys work well enough (a blood test will check this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study tests a quicker MRI screening approach for people with cirrhosis to look for liver cancer early. It may help make liver cancer checkups faster and easier while still finding cancers when they are small.
This study uses advanced imaging (MRI and contrast-enhanced ultrasound) with computer technology to help doctors decide the best treatment for early-stage liver cancer. It aims to improve outcomes for patients who undergo surgery or microwave ablation.
This study compares MRI and ultrasound to see which is better at finding liver cancer early in people with liver cirrhosis. It also looks at body composition and other factors that could lead to worsening liver function.
This trial compares two types of scans to see which detects liver cancer better in people at high risk. You would receive either an MRI with contrast or an ultrasound every 6 months to monitor for liver cancer.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.